ABVC Biopharma Inc (ABVC) — Long-term Investment Intensity
ABVC Biopharma Inc (ABVC) has a Long-term Investment Intensity of 8.9% as of December 2025. Long-term investments of $1.88 Million represent 8.9% of total assets of $21.06 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See ABVC Biopharma Inc (ABVC) net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
ABVC Biopharma Inc Long-term Investment Intensity (2017–2025)
This chart shows how ABVC Biopharma Inc's Long-term Investment Intensity has evolved across 8 annual periods from 2017 to 2025. As of December 2025, the intensity stands at 8.9%, reflecting long-term investments of $1.88 Million against total assets of $21.06 Million USD. Also explore ABVC Biopharma Inc balance sheet assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for ABVC Biopharma Inc (2017–2025)
The table below presents the year-by-year Long-term Investment Intensity for ABVC Biopharma Inc from 2017 to 2025, covering 8 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of ABVC Biopharma Inc.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 8.9% | $1.88 Million | $21.06 Million | ▼ -21.0 pp |
| 2024 | 30.0% | $2.26 Million | $7.54 Million | ▼ -2.5 pp |
| 2023 | 32.5% | $2.53 Million | $7.78 Million | ▲ +24.8 pp |
| 2022 | 7.7% | $842.07K | $10.93 Million | ▲ +0.9 pp |
| 2021 | 6.8% | $932.75K | $13.70 Million | ▼ -1.3 pp |
| 2020 | 8.1% | $1.19 Million | $14.77 Million | ▼ -40.5 pp |
| 2019 | 48.6% | $3.36 Million | $6.93 Million | ▼ -14.8 pp |
| 2017 | 63.4% | $4.19 Million | $6.60 Million | — |